Please login to the form below
Deloitte
This page shows the latest Deloitte news and features for those working in and with pharma, biotech and healthcare.
The forefront of technology innovation
These are among Deloitte’s predictions for life sciences and the future for drugs companies and their operations, from The Future Awakens: Life Sciences and Health Care Predictions 2022 (Deloitte, November
Latest news
-
Orphan drugs dominate FDA's record-breaking year
A study published in December by Deloitte showed that R&D costs have doubled in eight years, while peak sales forecasts have halved.
-
Pharma’s R&D productivity sinks to a new low
The research by Deloitte’s Centre for Health Solutions found returns had declined 1.8 percentage points from 3.7% in 2017. ... Deloitte says the industry needs to tackle the problem with new ways of working and emphasis on finding the right talent.
-
Artificial intelligence in healthcare
According to a Deloitte report, AI ‘can help analyse large data sets from sources such as clinical trials, health records, genetic profiles and preclinical studies; within this data, it can recognise ... Deloitte also suggests AI can help improve study
-
NHS bracing for 'no deal’ Brexit impact, including medicines
According to a Deloitte survey, 75% of British companies are now pessimistic about Brexit after weak investment and waning revenues in the most recent financial quarter.
-
Health insurers will test blockchain for data handling
A Deloitte report on the application of blockchain to healthcare published in 2016 predicted that the technology could “provide a new model for health information exchanges (HIE) by making electronic medical
More from news
Approximately 2 fully matching, plus 17 partially matching documents found.
Latest Intelligence
-
Emerging use cases of blockchain in healthcare and the life sciences
The Prescrypt project, spearheaded by Deloitte in the Netherlands, is pursuing a completely different focus by working to put patients’ drug prescriptions on the blockchain for secure communication, usage tracking and
-
Start small but think big
Deloitte’s Future of Work initiative highlights the increasingly important role that contractors, freelancers and external experts play in building the flexible and agile teams that companies need.
-
China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
at Deloitte Strategy Consulting, who specialises in the biotech sector. ... Deloitte’s Xiaofeng believes that China’s growth will benefit Europe and the rest of the world.
-
The Big Book of Dashboards
Steve Wexler has worked with ADP, Gallup, Deloitte, Convergys, Consumer Reports, The Economist, ConEd, D&B, Marist, Tradeweb, Tiffany, McKinsey &Company, and many other organisations to help them understand and visualise
-
The rise of real-world evidence
More than half the leading life science companies polled by Deloitte in 2017 were developing or significantly improving their real-world data (RWD) capabilities.
More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.
Latest appointments
-
New hires at Bristol-Myers Squibb, Acceleron and FerGene
Prior to that, she held several senior communications roles, including chief communications officer at Deloitte, as well as senior roles at Novartis, Pfizer and leadership roles at biotech and healthcare communications
-
Paul Stockdale joins Oxford BioDynamics as CFO
Stockdale arrives at the company from e-Therapeutics, where he had been financial controller since 2012, and has also previously served at Deloitte as a senior manager.
-
AlixPartners appoints new managing director
Previously healthcare and life sciences partner at Deloitte Consulting, Vogt has experience advising companies in the medtech, healthcare and pharmaceutical industries in implementing and improving strategies. ... Prior to his experience at Deloitte
-
Sanofi appoints Diane Souza and Thomas Südhof
Prior to this, Souza held the role of chief financial officer at Aetna, overseeing its guaranteed products business, and has also held senior leadership positions at Deloitte and PriceWaterhouseCooper.
-
Quantum Pharma promotes Chris Rigg to chief financial officer
He brings 20 years of financial and managerial experience to the role, having worked at Deloitte, Eaga, PriceWaterhouseCoopers and Barclays, where he headed up its North East corporate banking division.
More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.
Latest from PMHub
-
Impetus Digital Fireside Chat with Deloitte Europe: The Future of Learning
Natalie Yeadon, Co-owner/Managing Director at Impetus Digital, talks to Ladana Edwards and Thomas De Bruyne from Deloitte Europe about the future of education and learning.
-
From nature to art galleries: thinking differently about healthcare
Deloitte, 2019.Last accessed February 2020, available at: ). Accenture, 2019. Last accessed February 2020, available at: . Public Health England. Last accessed February 2020, available at: . 44 (0) 20 7009 3100. Address:.
-
RWE Blog 1: Real-world challenges and real-world data
RWD and RWE are high on the list of priorities for the top 20 pharmaceutical companies. According to Deloitte, 90% of them are investing in RWE capabilities across the entire product
-
More tell, less sell: HCP-centric comms
New York, NY: 2017. 9. Deloitte. Pharma Adoption of Social Media.
-
Using contextual moments in marketing
Deloitte Digital.
More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Medical Editor
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Account Director
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
- Nucleus Global announces a trio of promotions
- Sanofi, GSK delay COVID-19 vaccine trial after underwhelming results in elderly participants
- Pfizer introduces new logo in a ‘shift from commerce to science’
- New study identifies drugs that are safe to use in COVID-19 treatment
- PHE study finds people who have had COVID-19 can still transmit the virus
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- Mistrust in medical research: a patient perspective
- Real-world evidence: breaking boundaries in rare disease
- Live Webinar: Importance of Highlighting Patient Voices, Workforce Well-Being, and Health Literacy During and After the Pandemic
- The heavy toll of COVID-19 on cancer patients
- Unpacking rare diseases in the first edition of Delta magazine
- Virtual HealthTech conference powered by Impetus Digital: A Customer Story
PMHub
Videum Health
Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...
Latest intelligence
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...
Quick links
Infographics
